Showing results (61-70 of 92) with videos related to
Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2012
IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cellsGuoyan Cheng, Xiaomei Yuan, Matthew S Tsai, et al.Diabetes|January 11, 2015
Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetesAixin Yu, Isaac Snowhite, Francesco Vendrame, et al.Blood|April 2, 2014
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in miceRobert G Newman, Michael J Dee, Thomas R Malek, et al.Cancer Immunology, Immunotherapy : CII|October 10, 2020
Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunityRosmely Hernandez, Kevin H Toomer, Janika Põder, et al.Nature Reviews. Drug Discovery|October 13, 2018
Regulatory T cells in the treatment of diseaseAmir Sharabi, Maria G Tsokos, Ying Ding, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2022
CCL21 and beta-cell antigen releasing hydrogels as tolerance-inducing therapy in Type I diabetesFlavia Zisi Tegou, Diana Velluto, Aaron A Stock, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2017
The Lower Limit of Regulatory CD4+ Foxp3+ TCRβ Repertoire Diversity Required To Control AutoimmunityAixin Yu, Michael J Dee, Dennis Adeegbe, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2013
IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineagesJessica J Ashbaugh, Roberta Brambilla, Shaffiat A Karmally, et al.Immunohorizons|December 18, 2020
Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T CellsSunnie Hsiung, Alejandro Moro, Yuguang Ban, et al.Iscience|June 10, 2025
Growth of human regulatory CD4+ T cells is more tightly controlled than effector T cells due to distinctive molecular programmingAlejandro Moro, Aixin Yu, Luis Nivelo, et al.Pageof 10